The TJX Companies, Inc.
TJX - NYSE - $156.83 ▲ +%0.05
-
Earnings Wed 20 May
Note: this preview was published before the 2026-05-20 earnings report. Results have since been released — verify against the latest filings.

TJX opens the
books on Wednesday evening.

1 analysts' median target is $170[FMP target], stock is $157, +8.4% upside potential. After Q2 +2.9% EPS beat[FMP earnings], the stock moved +1.8%.

summary below
Quick Take - in 40 seconds
B
HOLD Council 2/6 - Moonshot 57

B = MoonshotScore 57[9-pillar formula] + Council 2/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].

Q4 consensus: revenue $14.0B[FMP est], EPS $1.00[FMP est]. 8 consecutive quarters of beat[FMP earnings].

$1.00 EPS Estimate Last year $1.23 - +9% YoY YoY
8 Beat Streak Expectations beaten consecutively for the last 8 quarters

Q2 EPS +2.9% beat[FMP] but the stock +1.8% D+1[FMP D+1]. John Klinger promised $468.0M CapEx + a sequential decline in Q4 during the Q2 earnings call[John Klinger capex transcript].

Watchlist

5 metrics stand out this quarter.

11.4% Risk Indicator

Profit Margin Increase

profit_margin_increase

TJX reported a second-quarter pre-tax profit margin of 11.4%, up 50 basis points versus last year and well above plan.

"Second quarter pre-tax profit margin of 11.4% was up 50 basis points versus last year and well above our plan."

- John Klinger - Q2 FY26 Earnings Call - August 20, 2025
4% Investor Focus

Comp Sales Growth

comp_sales_growth

TJX reported a better-than-expected consolidated comp sales increase of 4% in the second quarter, with customer transactions up at every division.

"Overall, comp sales for the second quarter exceeded our expectations, increasing 4% and were strong across all of our divisions. Customer transactions were up at every division and drove our overall comp sales increase."

- Ernie Herrman - Q2 FY26 Earnings Call - August 20, 2025
5% Investor Focus

Tjx International Growth

tjx_international_growth

TJX International reported a very strong comp sales increase of 5%, with strong sales in Europe and outstanding sales in Australia.

"At TJX International, comp sales increased a very strong 5%. Once again, we're very pleased to see sales strength in Europe and outstanding sales in Australia."

- John Klinger - Q2 FY26 Earnings Call - August 20, 2025
14% Investor Focus

Merchandise Availability

merchandise_availability

TJX reported that balance sheet inventory was up 14%, and inventory on a per-store basis was up 10% versus last year, as they've been buying into the excellent opportunities for quality, branded merchandise they've been seeing in the marketplace.

"Balance sheet inventory was up 14%, and inventory on a per-store basis was up 10% versus last year, as we've been buying into the excellent opportunities for quality, branded merchandise we've been seeing in the marketplace."

- John Klinger - Q2 FY26 Earnings Call - August 20, 2025
3% Investor Focus

Marmaxx Performance

marmaxx_performance

Marmaxx saw strong comp sales growth of 3%, driven by a combination of a higher average basket and an increase in customer transactions, with strength in store performance across all income demographics.

"At Marmaxx, comp sales grew a strong 3%. A combination of a higher average basket and an increase in customer transactions drove the comp increase. It was great to see strength in our store performance across all income demographics, which speaks to our broad-based appeal of our values."

- John Klinger - Q2 FY26 Earnings Call - August 20, 2025

Stock Expert AI - Methodology

Do our 9 pillars, 7 perspectives, and Munger lens point in the same direction?

Council Score 2 / 6 Bullish

6 investor frameworks. 2 bullish (Ray Dalio, Buffett), 1 bearish (Ken Griffin), 3 neutral (Jim Simons, Klarman, Munger).

How is it calculated? ->
Ray Dalio macro - target upside +8.4%
Ken Griffin flow - 50d MA below
Jim Simons quant - RSI 46
Klarman value - target upside +8.4%
Buffett quality - ROE score 5/5
Munger valuation - target upside +8.4%
Munger's Mindset character & balance sheet lens
Fairly Valued

Quality business, trading at fair value.

How is it calculated? ->
Financial HealthModerate
Margin of SafetyWeak
Interest CoverageAdequate
ROIC vs WACCHealthy
Technical Levels - Pre-earnings positioning

What levels is the stock being tested at?

RSI(14)
45.8 RSI 45.8 balanced, 50d below
MACD
-1.00 price below 50d - resistance dominant
50d MA
$158 stock 1.0% below - short-term resistance
200d MA
$148 stock 5.9% above - long-term support
Volume (10d)
+15% increase - pre-earnings positioning
Resistance
$170
Analyst median target - upgrade trigger if broken
Current
$157
Pre-earnings position
Support
$126
Invalidation - close below this is a technical breakdown
Pattern
Range
$126-$170 band - earnings breakout/breakdown trigger

Past Performance

The beat expectations in the last 8 quarters.

BEAT
Q1 FY26
$0.92 vs $0.92 est - -1.1%
BEAT
Q2 FY26
$1.10 vs $1.01 est - -0.5%
BEAT
Q3 FY26
$1.28 vs $1.23 est - +1.5%
BEAT
Q4 FY26
$1.43 vs $1.39 est - +1.8%

Q2 (August 20, 2025): EPS $1.43 vs $1.39 est[FMP], +2.9% beat. D+1 movement: +1.8%[FMP D+1]. Decline despite beat - market reacted to guidance, not numbers.

Three scenarios: what could happen?

EPS < $0.97 (no guidance)

Q2: EPS $1.43 vs $1.39 beat[FMP], stock +1.8% D+1[FMP].

Backlog concentration

No RPO/backlog concentration disclosed in Q2 earnings call.

CapEx shock

Q2 CapEx $468.0M[FMP cashflow]. Q2 op margin 13.3%[FMP op margin] - this level in Q4 is sensitive to CapEx revision risk.

Framework - Position discipline

After the data arrives: 3 scenarios, 3 windows

Not advice - a structural framework for earnings night. Decision discipline is yours.

Scenario A - Beat
Q4 EPS > $1.00 + CapEx discipline
Threshold: EPS > $1.00[FMP est].
Target: Break above median target $170[FMP target]; high target $193[FMP] upper bound.
Scenario B - In-Line
EPS approx $1.00 + CapEx < $468.0M
Threshold: EPS approx $1.00[FMP est], Q4 CapEx < $468.0M[FMP].
Target: Consolidation in the band between current $157[FMP] and median $170[FMP].
Scenario C - Miss
EPS < $0.97 or CapEx >= $468.0M
Threshold: EPS < $0.97[FMP estx0.97].
Target: Current $157 below SMA200 $148[FMP], if rejection continues, $126[derived] support activates.
Sizing
Earnings volatility -> max portfolio 1-2%. Waiting for earnings is not a gamble, it's a position entrustment.
Timing
IV crush within 24 hours post-earnings. Waiting for premium decay makes options preferable to spot.
Staging
Don't go all-in at once, divide into 3: initial reaction, 24 hours later, after Friday's close.

Market Outlook

What do 1 analysts say?

Wall Street Consensus
$170
12-month median target price (+8.4% upside potential)
18
BUY
1
HOLD
1
SELL
Risk Management
$126
Invalidation level - critical support threshold
$158 - 50-day MA (below, -1.0%)
$148 - 200-day MA (above, +5.9%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - TJX Q4 FY26
B

You read it in 5 minutes. When the numbers come out on Wednesday evening - you know what you're looking at.

Data arrives at night. The framework is ready now.

Data arrives on Wednesday evening. The framework is ready on this page: Q4 EPS threshold $1.00[FMP], CapEx threshold "below $468.0M"[John Klinger]. Two anchors, three scenarios.

Comparison Stock Expert AI Pro $24/month ($240/year), 77% cheaper than the total of three earnings-tracking tools ($1,059/year -> $240/year).

3 subscriptions. 1 platform.

Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts

Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing

Stock Expert AI Pro: $24/month ($240/year). Council 7-lens analysis + MoonshotScore 9-pillar + Insider tracker + Technical levels - all in one platform, for every stock.

Educational tool, not investment advice. Past performance does not guarantee future results.

Calendar

Catalyst Calendar - 90-day forward look

May 20, 2026EARNINGSQ4 FY26 results (after market close) + earnings call
May 21, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Jul 4, 2026FILING10-Q deadline - segment breakdown + RPO detail (SEC rule: quarter-end + 45 days)
~Aug 20, 2026EARNINGSQ1 FY27 (next quarter, date not yet scheduled in FMP)

DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.

Frequently Asked Questions

What does the TJX earnings preview cover?

This TJX (TJX) earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.

What should investors watch for in TJX earnings?

Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.